Table 3.
Summary of Data of the Included Publications Relevant to Key Question 3: For Children With Chronic Cough (> 4 Weeks Duration) Who Do Not Have an Underlying Lung Disease, With or Without Gastrointestinal GER Symptoms, What GER-Based Therapies Should Be Used and for How Long? (If We Find No to Q1, Q2 Should Be Omitted)
| Paper and Year | Evidence Level | Key Relevant Recommendation | Comment |
|---|---|---|---|
| de Benedictis and Bush, 20188 | Not stated | “Children with chronic cough and typical symptoms of GERD should undergo medical treatment—dietary, lifestyle modifications and acid suppression therapy. Here, we suggest that a three-stage therapeutic trial should be completed before diagnosing reflux-related cough: (1) clear-cut response to a 4 to 8-week treatment with PPI; (2) relapse on stopping medication; (3) new response to recommencing medication, with weaning down therapy as appropriate to the child’s symptoms”8 | PRISMA data not shown |
| NASPGHAN and ESPGHAN guideline, 20181 | Expert opinion | No specific recommendation for children with cough and GERD but it is implied that GERD on its own should be treated. In the treatment of GERD: “Based on expert opinion, the working group recommends evaluation of treatment efficacy and exclusion of alternative causes of symptoms in infants and children not responding to 4 to 8 weeks of optimal medical therapy for GERD.”1 Strong recommendation | GER-specific systematic review and guideline |
| NICE guideline, 20152 | Experience and opinion of the group | No specific recommendation for children with cough and GERD but it is implied that GERD on its own should be treated. For GERD treatment, “Assess the response to a 4 week trial of the PPIs or H2 receptor antagonist and consider referral to a specialist for possible endoscopy if the symptoms do not resolve or recur after stopping the treatment”2 | GER-specific systematic review and guideline |
See Table 1 legend for expansion of abbreviations.